Maxim Group Initiates Coverage On Nasus Pharma with Buy Rating, Announces Price Target of $7
Benzinga Newsdesk 2 days ago
Analyst RatingsNewsInitiationPrice Target
Maxim Group analyst Naz Rahman initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Target of $7.
Maxim Group analyst Naz Rahman initiates coverage on Nasus Pharma (AMEX:NSRX) with a Buy rating and announces Price Target of $7.